NYSE:MET - Metlife Stock Price, News, & Analysis

Metlife trades on the New York Stock Exchange (NYSE) under the ticker symbol "MET."

Metlife declared a quarterly dividend on Friday, July 6th. Investors of record on Monday, August 6th will be given a dividend of $0.42 per share on Thursday, September 13th. This represents a $1.68 annualized dividend and a yield of 3.66%. The ex-dividend date of this dividend is Friday, August 3rd. View Metlife's Dividend History.

Metlife announced that its Board of Directors has authorized a share buyback plan on Tuesday, May 22nd 2018, which permits the company to buyback $1,500,000,000.00 in outstanding shares, according to EventVestor. This buyback authorization permits the company to reacquire up to 3.1% of its shares through open market purchases. Shares buyback plans are often a sign that the company's leadership believes its shares are undervalued.

Metlife Inc (NYSE:MET) posted its earnings results on Wednesday, August, 1st. The financial services provider reported $1.30 EPS for the quarter, beating the Zacks' consensus estimate of $1.17 by $0.13. The financial services provider earned $21.22 billion during the quarter, compared to analyst estimates of $15.65 billion. Metlife had a net margin of 6.12% and a return on equity of 9.17%. The business's quarterly revenue was up 36.8% compared to the same quarter last year. During the same quarter in the prior year, the company earned $1.04 earnings per share. View Metlife's Earnings History.

Metlife is scheduled to release their next quarterly earnings announcement on Wednesday, November, 7th 2018. View Earnings Estimates for Metlife.

15 brokers have issued 12 month price objectives for Metlife's stock. Their forecasts range from $48.00 to $63.00. On average, they expect Metlife's share price to reach $55.00 in the next twelve months. This suggests a possible upside of 19.7% from the stock's current price. View Analyst Price Targets for Metlife.

15 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Metlife in the last year. There are currently 8 hold ratings and 7 buy ratings for the stock, resulting in a consensus recommendation of "Hold." View Analyst Ratings for Metlife.

Metlife saw a increase in short interest during the month of July. As of July 13th, there was short interest totalling 14,206,280 shares, an increase of 18.2% from the June 29th total of 12,020,301 shares. Based on an average daily trading volume, of 4,474,570 shares, the short-interest ratio is presently 3.2 days. Approximately 1.6% of the shares of the company are short sold. View Metlife's Current Options Chain.

Some companies that are related to Metlife include China Life Insurance (LFC), AXA (AXAHY), Prudential Public (PUK), Prudential Financial (PRU), Manulife Financial (MFC), SWISS RE Ltd/S (SSREY), AVIVA PLC/ADR (AVVIY), Sun Life Financial (SLF), HANNOVER RUECK/S (HVRRY), Legal & General Group (LGEN), AMP (AMP), Lincoln National (LNC), OLD Mut PLC/ADR (ODMTY), AEGON (AEG) and Athene (ATH).

Media coverage about MET stock has trended somewhat positive this week, Accern Sentiment reports. Accern identifies positive and negative media coverage by reviewing more than twenty million news and blog sources in real time. Accern ranks coverage of public companies on a scale of negative one to positive one, with scores closest to one being the most favorable. Metlife earned a coverage optimism score of 0.11 on Accern's scale. They also assigned news headlines about the financial services provider an impact score of 48.94 out of 100, meaning that recent media coverage is somewhat unlikely to have an effect on the company's share price in the near term. View Recent Headlines for Metlife.

Metlife's stock is owned by a variety of of retail and institutional investors. Top institutional investors include BlackRock Inc. (7.11%), FMR LLC (4.60%), Massachusetts Financial Services Co. MA (2.41%), Bank of New York Mellon Corp (1.28%), Diamond Hill Capital Management Inc. (1.04%) and Epoch Investment Partners Inc. (0.87%). Company insiders that own Metlife stock include Christopher G Townsend, Frans Hijkoop, Gerald L Hassell, James M Kilts, Maria R Morris and Peter M Carlson. View Institutional Ownership Trends for Metlife.

MET stock was sold by a variety of institutional investors in the last quarter, including American Century Companies Inc., Epoch Investment Partners Inc., BlackRock Inc., Canada Pension Plan Investment Board, Bank of Montreal Can, Jennison Associates LLC, Caisse DE Depot ET Placement DU Quebec and United Services Automobile Association. View Insider Buying and Selling for Metlife.

MET stock was bought by a variety of institutional investors in the last quarter, including FMR LLC, Pzena Investment Management LLC, Morgan Stanley, Robeco Institutional Asset Management B.V., Putnam Investments LLC, Sumitomo Mitsui Trust Holdings Inc., LSV Asset Management and First Trust Advisors LP. Company insiders that have bought Metlife stock in the last two years include Gerald L Hassell and James M Kilts. View Insider Buying and Selling for Metlife.

Shares of MET can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.

One share of MET stock can currently be purchased for approximately $45.94.

Metlife has a market capitalization of $44.42 billion and generates $62.09 billion in revenue each year. The financial services provider earns $4.01 billion in net income (profit) each year or $4.50 on an earnings per share basis. Metlife employs 49,000 workers across the globe.

Metlife's mailing address is 200 Park Avenue, New York NY, 10166. The financial services provider can be reached via phone at 212-578-9500.